Cgp 29287

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H597585

CAS#: 93287-54-8

Description: Cgp 29287 is a primate-specific renin inhibitor with prolonged duration of action.


Chemical Structure

img
Cgp 29287
CAS# 93287-54-8

Theoretical Analysis

Hodoodo Cat#: H597585
Name: Cgp 29287
CAS#: 93287-54-8
Chemical Formula: C72H110N20O15
Exact Mass: 1,494.85
Molecular Weight: 1,495.790
Elemental Analysis: C, 57.81; H, 7.41; N, 18.73; O, 16.04

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Cgp 29287; Cgp-29287; Cgp29287; Cgp-29,287; Cgp 29,287; Cgp29,287;

IUPAC/Chemical Name: methyl N2-((3S,4S)-4-((S)-2-((S)-2-((S)-1-(((benzyloxy)carbonyl)-L-arginyl-L-arginyl)pyrrolidine-2-carboxamido)-3-phenylpropanamido)-3-(1H-imidazol-4-yl)propanamido)-3-hydroxy-6-methylheptanoyl)-L-isoleucyl-L-histidyl-N6-(tert-butoxycarbonyl)-L-lysinate

InChi Key: DLAHCJHYEAZDLE-VRYQDWSQSA-N

InChi Code: InChI=1S/C72H110N20O15/c1-9-44(4)59(65(100)89-55(36-48-39-78-42-83-48)62(97)85-51(67(102)105-8)25-16-17-29-81-70(103)107-72(5,6)7)91-58(94)37-57(93)52(33-43(2)3)86-63(98)54(35-47-38-77-41-82-47)87-61(96)53(34-45-21-12-10-13-22-45)88-64(99)56-28-20-32-92(56)66(101)50(27-19-31-80-69(75)76)84-60(95)49(26-18-30-79-68(73)74)90-71(104)106-40-46-23-14-11-15-24-46/h10-15,21-24,38-39,41-44,49-57,59,93H,9,16-20,25-37,40H2,1-8H3,(H,77,82)(H,78,83)(H,81,103)(H,84,95)(H,85,97)(H,86,98)(H,87,96)(H,88,99)(H,89,100)(H,90,104)(H,91,94)(H4,73,74,79)(H4,75,76,80)/t44-,49-,50-,51-,52-,53-,54-,55-,56-,57-,59-/m0/s1

SMILES Code: O=C(OC)[C@H](CCCCNC(OC(C)(C)C)=O)NC([C@H](CC1=CNC=N1)NC([C@H]([C@@H](C)CC)NC(C[C@H](O)[C@@H](NC([C@H](CC2=CNC=N2)NC([C@H](CC3=CC=CC=C3)NC([C@H]4N(C([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC(OCC5=CC=CC=C5)=O)=O)=O)CCC4)=O)=O)=O)CC(C)C)=O)=O)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 1,495.79 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Samani NJ, Cumin F, Kelly M, Wood JM. Expression of components of the RAS during prolonged blockade at different levels in primates. Am J Physiol. 1994 Oct;267(4 Pt 1):E612-9. PubMed PMID: 7943312.

2: Humke U, Levens N, Wood J, Hofbauer K. Responses to renin inhibition in conscious primates. Am J Physiol. 1991 Jul;261(1 Pt 2):F179-86. PubMed PMID: 1907105.

3: Nussberger J, Brunner DB, Waeber B, Brunner HR. In vitro renin inhibition to prevent generation of angiotensins during determination of angiotensin I and II. Life Sci. 1988;42(17):1683-8. PubMed PMID: 2835564.

4: de Gasparo MM, Wood JM, Heusser CH. Mechanism of inhibition of human renin by monoclonal antibodies. Hypertension. 1988 Mar;11(3):209-16. PubMed PMID: 3280480.

5: Wood JM, Jobber RA, Baum HP, Hofbauer KG. Comparison of chronic inhibition of renin and converting enzyme in the marmoset. Clin Exp Hypertens A. 1987;9(2-3):337-43. PubMed PMID: 3038392.

6: Wood JM, Baum HP, Carleton J, Dzau VJ. Inhibition of renin-like activity in marmoset tissues by the renin inhibitor CGP 29 287. J Hypertens Suppl. 1987 Jul;5(2):S67-9. PubMed PMID: 3116182.

7: Wood JM, Gulati N, Forgiarini P, Fuhrer W, Hofbauer KG. Effects of a specific and long-acting renin inhibitor in the marmoset. Hypertension. 1985 Sep-Oct;7(5):797-803. PubMed PMID: 3928488.

8: Wood JM, Baum HP, Forgiarini P, Gulati N, Jobber RA, Neisius D, Hofbauer KG. Haemodynamic effects of acute and chronic renin inhibition in marmosets. J Hypertens Suppl. 1989 Apr;7(2):S37-42. PubMed PMID: 2547039.

9: Wood JM, Baum HP, Jobber RA, Neisius D. Sustained reduction in blood pressure during chronic administration of a renin inhibitor to normotensive marmosets. J Cardiovasc Pharmacol. 1987;10 Suppl 7:S96-8. PubMed PMID: 2485073.

10: Wood JM, Jobber RA, Baum HP, de Gasparo M, Nussberger J. Biochemical effects of prolonged renin inhibition in marmosets. J Hypertens. 1989 Aug;7(8):615-8. PubMed PMID: 2681408.

11: Neisius D, Wood JM, Hofbauer KG. Renal vasodilatation after inhibition of renin or converting enzyme in marmoset. Am J Physiol. 1986 Nov;251(5 Pt 2):H897-902. PubMed PMID: 3022608.

12: Hofbauer KG, Fuhrer W, Heusser C, Wood JM. Comparison of different drug interference with the renin-angiotensin system. J Cardiovasc Pharmacol. 1985;7 Suppl 4:S62-8. PubMed PMID: 2412016.

13: Hofbauer KG, Wood JM, Gulati N, Heusser C, Ménard J. Increased plasma renin during renin inhibition. Studies with a novel immunoassay. Hypertension. 1985 May-Jun;7(3 Pt 2):I61-5. PubMed PMID: 2987126.

14: Neisius D, Wood JM. Antihypertensive effect of a renin inhibitor in marmosets with a segmental renal infarction. J Hypertens. 1987 Dec;5(6):721-5. PubMed PMID: 2828470.

15: Song K, Miyazaki M, Okunishi H, Ishii K, Takai S, Shiota N, Kim S, Mendelsohn FA. Localization and quantitation of active renin in monkey kidney by radioinhibitor binding and in vitro autoradiography. Am J Hypertens. 1994 Jun;7(6):529-35. PubMed PMID: 7917151.